Mallinckrodt highlights patient success stories to spruce up its image—and the industry’s

Mallinckrodt Pharmaceuticals' "Patient Stories" marketing campaign uses patients to highlight the value of prescription medicine.

Even as Mallinckrodt Pharmaceuticals made headlines for its FTC settlement, the company was working on its reputation with a corporate ad campaign. Television commercials airing recently in local markets feature patients and employees detailing how prescription drugs helped them in a series of “Patient Stories” ads.

While short on specific details—the videos don’t reveal what illnesses patients had or what treatments they used—the ads are long on praise for Mallinckrodt and the pharma industry.

Each video opens with the words “Patient Stories brought to you by Mallinckrodt Pharmaceuticals,” followed by individual stories from caregivers or patients about how they, or their loved ones, were helped by prescribed medications. The ads all end with a variation on the phrase: “Thank you to the people at companies like Mallinckrodt for making medicines that make a difference in my life.”

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

The “Patient Stories” videos also reside on the Mallinckrodt website and rolled out on the company's YouTube channel in August. Mallinckrodt did not respond to requests for comment about the work.

Along with many of its specialty pharma peers, Mallinckrodt has faced intense company scrutiny and criticism over the past two years around drug pricing. Using marketing to remind people of the difference that prescription drugs can make may be one way to improve its reputation, and the industry’s, with stakeholders and consumers.

And Mallinckrodt isn't the only one to give it a shot. Amid political pressure and public pricing pushback, several other pharma companies and associations have launched similar reputation-building efforts. Pfizer’s “Before it Became a Medicine” TV ad, Merck’s online “Humans for Health” and Astellas Pharma’s corporate ads on CNN tell stories of employees hard at work to make a difference. Efforts from trade associations BIO and PhRMA, which recently launched a new push, have tried to point out the benefits of prescription drugs through the eyes of patients, pharma employees and scientists.

Suggested Articles

The second of AbbVie’s highly anticipated 2019 blockbuster candidates is here: Its crucial Humira follow-up, Rinvoq.

Bristol-Myers Squibb’s takeover of Celgene hasn’t always gone smoothly, but now a once-left-for-dead centerpiece of that deal is ready to launch.

Investors sued Novo Nordisk in Denmark, claiming it misled the public about trouble plaguing its insulin franchise—and demanding $1.75B in damages.